Creating protein folds

An exon, the basic unit of DNA that gets shuffled around during evolution, has an average coding capacity of 40 amino acids, or roughly half of a small folded protein domain. Exon exchange between homologous proteins can lead to slightly altered proteins, but in the August 29 Proceedings of the National Academy of Sciences Riechmann and Winter ask whether shuffling between unrelated sequences can generate new folds (Proc Natl Acad Sci USA 2000, 97:10068-10073). Their starting material is DNA enc

By | September 4, 2000

An exon, the basic unit of DNA that gets shuffled around during evolution, has an average coding capacity of 40 amino acids, or roughly half of a small folded protein domain. Exon exchange between homologous proteins can lead to slightly altered proteins, but in the August 29 Proceedings of the National Academy of Sciences Riechmann and Winter ask whether shuffling between unrelated sequences can generate new folds (Proc Natl Acad Sci USA 2000, 97:10068-10073). Their starting material is DNA encoding half of a beta-barrel domain, plus fragmented genomic DNA from Escherichia coli. The fusion products that can fold are selected by their resistance to proteolysis; one of these proteins is significantly more stable than the original intact protein. The genomic segments that survive the selection do not share sequence homology with the starting beta-barrel sequence, although beta structure predominates in the final protein products.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech